湖南黃金(002155.SZ):子公司擬收購巨龍礦業擁有的曲溪金礦探礦權
格隆匯2月10日丨湖南黃金(002155.SZ)公佈,2022年2月8日,公司全資子公司黃金洞礦業與巨龍礦業簽訂《探礦權轉讓合同》,擬收購巨龍礦業擁有的湖南省平江縣曲溪礦區金礦普查探礦權(簡稱曲溪金礦探礦權)。
合同中的轉讓標的曲溪金礦為探礦權,金金屬量為1436千克(其中282千克為334,屬於未查明礦產資源,有無經濟意義尚不確定),勘查階段僅為普查階段,礦區勘查程度偏低,尚不具備開採條件。
基於合同約定的各項條件,根據雙方認可的專業評估機構作出的評估定價,並經雙方協商確定該合同項下探礦權及該探礦權井下巷道設施的轉讓價款合計為人民幣2302.97萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.